Ranking Alexa Global: # 4,298,151
Server:Apache...
X-Powered-By:PHP/5.5.22
The main IP address: 66.96.149.25,Your server United States,Burlington ISP:The Endurance International Group Inc. TLD:com CountryCode:US
The description :gelesis is transforming obesity and diabetes treatments. learn how our smart pill (gs100) can safely treat obese and diabetic patients....
This report updates in 08-Sep-2018
Created Date: | 2006-02-13 |
Changed Date: | 2018-01-29 |
Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host gelesis.com. Currently, hosted in United States and its service provider is The Endurance International Group Inc. .
Latitude: | 42.508480072021 |
Longitude: | -71.201133728027 |
Country: | United States (US) |
City: | Burlington |
Region: | Massachusetts |
ISP: | The Endurance International Group Inc. |
HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache containing the details of what the browser wants and will accept back from the web server.
Content-Length: | 11320 |
X-Powered-By: | PHP/5.5.22 |
Age: | 0 |
Server: | Apache |
Connection: | keep-alive |
Date: | Sat, 08 Sep 2018 04:47:47 GMT |
Content-Type: | text/html |
soa: | ns1.dotster.com. dnsadmin.dotster.com. 2012112708 10800 3600 604800 3600 |
txt: | "v=spf1 include:spf.protection.outlook.com -all" "MS=ms90531780" |
ns: | ns1.dotster.com. ns2.dotster.com. |
ipv4: | IP:66.96.149.25 ASN:29873 OWNER:BIZLAND-SD - The Endurance International Group, Inc., US Country:US |
mx: | MX preference = 0, mail exchanger = gelesis-com.mail.protection.outlook.com. |
toggle navigation menu about us why gelesis? leadership team clinical advisors board of directors -- people leadership team advisors board of directors unmet needs science technology gelesis100 pipeline posters presentations press gelesis in the news press releases contact us careers terms and conditions -- targeting the body's natural gi processes to treat the genesis of chronic disease gelesis is a biotechnology company developing a novel category of potential therapies for gi-related chronic diseases including obesity, nafld/nash, ibd and type 2 diabetes by targeting the natural processes of the gi pathway. learn more utilizing our novel hydrogel platform technology and the emerging science of mechanobiology , we are developing innovative approaches to target the cause of those epidemics rather than just improving their symptoms. our first-in-class products are designed to trigger multiple mechanisms throughout the gi system related to satiety, glycemic control, gut permeability and inflammation. we are a multi-disciplinary team, highly motivated and committed to making a difference in the fight against modern chronic diseases. we believe that the gi system holds the key to many of the world’s largest epidemics. modern lifestyle is the main cause of diseases such as obesity, diabetes or nash. we believe we can empower people to improve and change their diet, lifestyle and health. read about our first product candidate – gelesis100 read more about our hydrogel platform technology unmet needs innovative technology experienced leadership the unmet need technology why gelesis pipeline press -- contact us terms & conditions privacy policy © 2017 gelesis. | all rights reserved. | www.gelesis100.com
https://www.gelesis.com/careers.php
https://www.gelesis.com/videos.php
https://www.gelesis.com/terms-conditions.php
https://www.gelesis.com/unmet-needs.php
https://www.gelesis.com/scientific-advisors.php
https://www.gelesis.com/privacy-policy.php
https://www.gelesis.com/press-releases.php
https://www.gelesis.com/gelesis100.php
https://www.gelesis.com/our-approach.php
https://www.gelesis.com/leadership-team.php
https://www.gelesis.com/newsroom.php
https://www.gelesis.com/publications.php
https://www.gelesis.com/board-directors.php
https://www.gelesis.com/clinical-trials.php
Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;
Domain Name: GELESIS.COM
Registry Domain ID: 344413706_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.domain.com
Registrar URL: http://www.domain.com
Updated Date: 2018-01-29T16:56:09Z
Creation Date: 2006-02-13T17:12:43Z
Registry Expiry Date: 2019-02-13T17:12:43Z
Registrar: Domain.com, LLC
Registrar IANA ID: 886
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: 602-226-2389
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS1.DOTSTER.COM
Name Server: NS2.DOTSTER.COM
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-09-08T04:48:25Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
REGISTRAR Domain.com, LLC
SERVERS
SERVER com.whois-servers.net
ARGS domain =gelesis.com
PORT 43
TYPE domain
DOMAIN
NAME gelesis.com
CHANGED 2018-01-29
CREATED 2006-02-13
STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
NSERVER
NS1.DOTSTER.COM 66.96.142.146
NS2.DOTSTER.COM 65.254.254.170
REGISTERED yes
The following list shows you to spelling mistakes possible of the internet users for the website searched .